Central Pharmaceutical JSC No2 (HSTC:DP2) Asset Impairment Charge: ₫0.00 Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSTC:DP2 Central Pharmaceutical JSC No2 HSTC:DP2
23 GF Score
Price ₫4,900.00
View Full Analysis

What is Central Pharmaceutical JSC No2 Asset Impairment Charge?

Central Pharmaceutical JSC No2 HSTC:DP2 23 Asset Impairment Charge is ₫0.00 Mil as of . 20. GuruFocus rates HSTC:DP2 with a GF Score™ of 23/100.

Central Pharmaceutical JSC No2's Asset Impairment Charge for the six months ended in . 20 was ₫0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

Central Pharmaceutical JSC No2 Asset Impairment Charge Related Terms

Central Pharmaceutical JSC No2 Asset Impairment Charge Historical Data

* Premium members only.

The historical data trend for Central Pharmaceutical JSC No2's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Central Pharmaceutical JSC No2 Asset Impairment Charge Chart

Central Pharmaceutical JSC No2 Annual Data
Trend
Asset Impairment Charge

Central Pharmaceutical JSC No2 Semi-Annual Data
Asset Impairment Charge
HSTC:DP2
23GF Score
Central Pharmaceutical JSC No2 HSTC:DP2
Asset Impairment Charge is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Central Pharmaceutical JSC No2 Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

What does a Asset Impairment Charge of ₫0.00 Mil mean?
Central Pharmaceutical JSC No2 (HSTC:DP2) has a Asset Impairment Charge of ₫0.00 Mil as of . 20.
Is Central Pharmaceutical JSC No2's Asset Impairment Charge too high?
Central Pharmaceutical JSC No2's current Asset Impairment Charge is ₫0.00 Mil. Overall, Central Pharmaceutical JSC No2 has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Central Pharmaceutical JSC No2's Asset Impairment Charge compare to ?
Central Pharmaceutical JSC No2's Asset Impairment Charge of ₫0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Impairment Charge for a Healthcare Providers & Services company?
A good Asset Impairment Charge depends on the Healthcare Providers & Services industry context. However, Asset Impairment Charge should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Impairment Charge mean?
A high Asset Impairment Charge can signal that a stock is expensive relative to its fundamentals. Central Pharmaceutical JSC No2's current Asset Impairment Charge is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Central Pharmaceutical JSC No2 stock overvalued right now?
Central Pharmaceutical JSC No2 (HSTC:DP2) has a current Asset Impairment Charge of ₫0.00 Mil. The current Asset Impairment Charge is ₫0.00 Mil. Central Pharmaceutical JSC No2's overall GF Score™ is 23/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Impairment Charge calculated?
Asset Impairment Charge is calculated from a company's financial statements. For Central Pharmaceutical JSC No2 (HSTC:DP2), the current Asset Impairment Charge is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Central Pharmaceutical JSC No2 Business Description

Comparable Companies
Address No. 9 Tran Thanh Tong, Bach Dang Ward, Hai Ba Trung District, Hanoi, VNM
Central Pharmaceutical JSC No2 is engaged in the Trading of medicinal materials, pharmaceutical materials, chemicals, essential oils, modern medicines, traditional medicine drugs, cosmetics, and nutritious foods. Some of its products include Gentamycin injection solution 80; Genatreson Skin Cream; Ferimax Hard Capsules and others.
23GF Score

Get the complete analysis for HSTC:DP2

Asset Impairment Charge is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫4,900.00
Price